Search Results

You searched for : Remidio  

Smartphone Diagnostics: Phones as Medical Screening Tools

Smartphones are transforming medical screening in India through AI-powered tools that detect tuberculosis, diabetic retinopathy, diabetes risk, and cardiac irregularities, bridging critical diagnostic access ...
Nov 21

Remidio’s Diabetic Retinopathy AI Demonstrates Strong, Balanced Performance in Largest Real-World Evaluation Published in The Lancet Digital Health

Remidio Innovative Solutions today announced the publication of a landmark independent evaluation of regulatory-approved diabetic retinopathy (DR) artificial intelligence algorithms in The Lancet Digital ...
Jan 23

A breakthrough in myopia care: Remidio unveils PRISTINE OBM 12 with automatic capture for accurate pediatric measurements

Myopia is rising at an unprecedented rate globally, affecting nearly 30 percent of the world’s population today and projected to reach 50 percent by ...
Dec 19

Narayana Nethralaya’s KIDROP leads the way in preventing infant blindness beyond Karnataka

Infants born prematurely—before 34 weeks of gestation or weighing less than 2000 grams at birth—are at high risk of developing several health complications....
Nov 19

Narayana Nethralaya’s KIDROP leads the way in preventing infant blindness beyond Karnataka

Infants born prematurely—before 34 weeks of gestation or weighing less than 2000 grams at birth—are at high risk of developing several health complications....
Nov 19

Medtech Startup Remidio Launches Neubo 130, A Breakthrough in AI-Enabled Retinal Imaging for Newborns

Remidio Innovative Solutions, a leader in AI-powered ophthalmic devices, today announced the launch of Neubo 130, a next-generation ultra-widefield neonatal retinal imaging ...
Nov 07

Made in India, Scaling Globally: "Remidio Secures CE Marking for Dual Offline Ophthalmic AI Developed in India"

Medios HI detects both glaucoma and diabetic retinopathy from the same retinal image offline in under 10 seconds, reinforcing Remidio’s position as India’s ...
Oct 22

Remidio Launches its new device ‘Pristine’, Innovating AI-Powered Eye Diagnostics with Dual Brand Strategy

Pristine Sets New Benchmark in In-Clinic Diagnostics with Multi-Modality Precision and Seamless Workflow....
May 21

Remidio’s Medios HI AI Tools for Glaucoma and AMD Receive CDSCO Approval, Strengthening AI-Led Eye Care

With these approvals, Remidio continues to lead in the development of AI-driven ophthalmic diagnostics, aiming to bridge the gap in eye care delivery and ...
May 02

Remidio with RetinaRisk to Strengthen AI-Driven Diabetic Retinopathy Screening in India and Iceland

Remidio Innovative Solutions, a global leader in AI-powered ophthalmic diagnostics, has announced a strategic partnership with RetinaRisk, a leading health tech company from Iceland, ...
Apr 15

Indian MedTech Leader Remidio invests in UK’s Occuity to Enhance Non-Invasive Global Disease Screening

Strategic Partnership to Advance Early Disease Detection with Cutting-Edge Optical Technology....
Mar 25

From Science Fiction to Reality: AI Now Detects Blindness Before It Starts

By combining artificial intelligence with medical expertise, Kerala is showing the world how to create a smarter, more efficient, and patient-centric healthcare system....
Feb 24

DRDO lab develops UV systems to sanitise gadgets, paper and currency

DRDO, Research Centre Imarat (RCI), has developed an automated contact less UVC sanitisation cabinet, called Defence Research Ultraviolet Sanitiser (DRUVS). It has been designed to ...
May 11

Remidio Innovative Solutions: Path-breaking Study in Diabetic Retinopathy Screening -- Using Smartphones and Automated-AI

Primary-care based Diabetic Retinopathy (DR) screening can enable early detection, avoiding blindness due to DR for close to 425 million people living with diabetes ...
Oct 10

AI-Integrated retinal-imaging device from India shows promising results in screening for Diabetic Retinopathy

The MEDIOS-AI, designed by Bangalore-based Remidio Innovative Solutions, will implement sensitive and scalable screening models for Diabetic Retinopathy....
Sep 27

AI-Integrated, Smartphone-Based Retinal-Imaging Device From India Shows Promising Results in Community Screening for Diabetic Retinopathy

Diabetic Retinopathy (DR), is asymptomatic and affects nearly 20% of the 70 million diabetic patients in India. ...
Sep 11

16 Matching result(s) found!

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026